Terri B. Sebree's most recent trade in Zynerba Pharmaceuticals Inc was a trade of 36,044 Common Stock done . Disclosure was reported to the exchange on Feb. 7, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Zynerba Pharmaceuticals Inc | Terri B. Sebree | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 36,044 | 573,615 (2%) | 0% | - | Common Stock | |
Zynerba Pharmaceuticals Inc | Terri B. Sebree | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.60 per share. | 07 Feb 2023 | 9,973 | 563,642 (2%) | 0% | 0.6 | 5,949 | Common Stock |
Zynerba Pharmaceuticals Inc | Terri B. Sebree | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 33,688 | 546,892 (2%) | 0% | - | Common Stock | |
Zynerba Pharmaceuticals Inc | Terri B. Sebree | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.60 per share. | 31 Jan 2023 | 9,321 | 537,571 (2%) | 0% | 0.6 | 5,548 | Common Stock |
Zynerba Pharmaceuticals Inc | Terri B. Sebree | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2023 | 170,000 | 513,204 (2%) | 0% | 0 | Common Stock | |
Zynerba Pharmaceuticals Inc | Terri B. Sebree | President | Sale of securities on an exchange or to another person at price $ 0.60 per share. | 23 Jan 2023 | 24,661 | 343,204 (1%) | 0% | 0.6 | 14,742 | Common Stock |
Zynerba Pharmaceuticals Inc | Terri B. Sebree | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2022 | 30,000 | 376,146 (1%) | 0% | - | Common Stock | |
Zynerba Pharmaceuticals Inc | Terri B. Sebree | President | Sale of securities on an exchange or to another person at price $ 1.10 per share. | 18 Jul 2022 | 8,281 | 367,865 (1%) | 0% | 1.1 | 9,109 | Common Stock |
Zynerba Pharmaceuticals Inc | Terri B. Sebree | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
Zynerba Pharmaceuticals Inc | Terri B. Sebree | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 85,000 | 346,146 (1%) | 0% | 0 | Common Stock | |
Zynerba Pharmaceuticals Inc | Terri B. Sebree | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2021 | 110,000 | 110,000 | - | - | Stock Option (right to buy) | |
Zynerba Pharmaceuticals Inc | Terri B. Sebree | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2021 | 75,000 | 261,146 (1%) | 0% | 0 | Common Stock |